Repare Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:N/A
Lead Investor(s):N/A

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Repare Therapeutics's estimated annual revenue is currently $15.8M per year.(?)
  • Repare Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Repare Therapeutics has 102 Employees.(?)
  • Repare Therapeutics grew their employee count by 44% last year.
  • Repare Therapeutics currently has 8 job openings.

Repare Therapeutics is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells. Its approach integrates insights from several fields of cell biology including DNA repair and synthetic lethality. Repare’s platform combines a proprietary, high throughput, CRISPR‐enabled gene editing target discovery method with high‐resolution protein crystallography, computational biology and clinical informatics. The company is backed by leading global healthcare investors including founding investor Versant Ventures and MPM Capital. For additional information, please visit